Home › Companies › COHERUS BIOSCIENCES INC. › 2024-2025

COHERUS BIOSCIENCES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and COHERUS BIOSCIENCES INC.’s Form 8-K, filed June 13, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.

7Reported items
116Asset managers
855Fund votes
June 11, 2025Main meeting date

Results at a glance

Meeting of June 11, 2025: 6 items on COHERUS BIOSCIENCES INC.’s Form 8-K, filed June 13, 2025: 3 elected · 3 approved.

Material dissent

Elect Director: Ali J. Satvat 71% of votes cast Elected Director under 80%
4. The amendment to the Company's 2014 Employee Stock Purchase Plan (the "ESPP Amendment") 79% of votes cast Approved Under 80%
3. A non-binding, advisory resolution to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote) 54.3% of votes cast Approved Say-on-pay under 70%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore COHERUS BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by COHERUS BIOSCIENCES INC.

These tallies are COHERUS BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

COHERUS BIOSCIENCES INC. — official shareholder meeting results, meeting held June 11, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Jill O'Donnell-Tormey, Ph.D.	32,769,503	--	--	6,158,468	36,656,283	84%	Elected	—
Elect Director: Michael Ryan	32,735,184	--	--	6,192,787	36,656,283	84%	Elected	—
Elect Director: Ali J. Satvat	27,759,763	--	--	11,168,208	36,656,283	71%	Elected	—
2. The selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025	74,500,950	776,953	306,351	--	0	99%	Approved	—
3. A non-binding, advisory resolution to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote)	19,179,927	16,164,644	3,583,400	--	36,656,283	54.3%	Approved	—
4. The amendment to the Company's 2014 Employee Stock Purchase Plan (the "ESPP Amendment")	27,741,397	7,585,461	3,601,113	--	36,656,283	79%	Approved	—

Source: COHERUS BIOSCIENCES INC., Form 8-K, filed with the SEC on June 13, 2025 — read the filing on EDGAR.

How asset managers voted at the COHERUS BIOSCIENCES INC. 2024-2025 meetings

Each item below shows how the 116 asset managers that disclosed a COHERUS BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of COHERUS BIOSCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Ali J. Satvat

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Meeting held June 11, 2025.

Combines 3 wordings of this item as funds reported it.

71% Majority: yes · of votes cast

FOR 71%WITHHELD

FOR: 27,759,763WITHHELD: 11,168,208

Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Ali J. Satvat

COHERUS BIOSCIENCES INC.’s own tally for this item (“Elect Director: Ali J. Satvat”): 27,759,763 for, 11,168,208 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected by a majority of votes cast each of the Class II director nominees below, Jill O'Donnell-Tormey, Ph.D., Michael Ryan and Ali J. Satvat, to the Board of Directors of the Company to hold office until the 2028 annual meeting of stockholders or until their successors …”
Support: 71% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 5,581,345 for, 2,143,537 withheld, 147,580 abstained.

FORWITHHOLD

FOR: 5,581,345ABSTAIN: 147,580WITHHOLD: 2,143,537

Largest asset managers voting on “To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their ” at COHERUS BIOSCIENCES INC., 2024-2025
Asset manager	For	Abstain	Withheld	Vote
Vanguard	3,202,385	0	0	For
Charles Schwab	0	0	986,197	Withhold
Delaware/Macquarie	900,000	0	0	For
SEI	0	0	857,296	Withhold
BlackRock	525,254	105,554	0	Mixed
Equitable	22,008	0	188,410	Mixed
Fidelity	177,047	0	0	For
BRIDGEWAY FUNDS INC	91,117	0	0	For
Lincoln Financial	83,905	0	0	For
WisdomTree	80,178	0	0	For
Global X	0	0	67,376	Withhold
Goldman Sachs	66,033	0	0	For
Northern Trust	63,724	0	0	For
AQR	62,143	0	0	For
AIG/SunAmerica	58,876	0	0	For
Pacific Life	50,901	0	0	For
QUANTITATIVE MASTER SERIES LLC	46,319	0	0	For
Bridge Builder Trust	41,829	0	0	For
MASTER INVESTMENT PORTFOLIO	0	34,806	0	Abstain
Voya	33,119	0	0	For
Brighthouse	0	0	29,534	Withhold
John Hancock	29,316	0	0	For
DWS	17,544	0	0	For
Calvert	0	0	9,819	Withhold
ProShares	7,748	0	0	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

2. Elect Director: Jill O'Donnell-Tormey, Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Meeting held June 11, 2025.

Combines 4 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD

FOR: 32,769,503WITHHELD: 6,158,468

Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Jill O'Donnell-Tormey, Ph.D.

COHERUS BIOSCIENCES INC.’s own tally for this item (“Elect Director: Jill O'Donnell-Tormey, Ph.D.”): 32,769,503 for, 6,158,468 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected by a majority of votes cast each of the Class II director nominees below, Jill O'Donnell-Tormey, Ph.D., Michael Ryan and Ali J. Satvat, to the Board of Directors of the Company to hold office until the 2028 annual meeting of stockholders or until their successors …”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 7,644,699 for, 227,763 withheld.

FOR

FOR: 7,644,699WITHHOLD: 227,763

Largest asset managers voting on “To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their ” at COHERUS BIOSCIENCES INC., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	3,202,385	0	For
Charles Schwab	986,197	0	For
Delaware/Macquarie	900,000	0	For
SEI	857,296	0	For
BlackRock	630,808	0	For
Equitable	22,008	188,410	Mixed
Fidelity	177,047	0	For
BRIDGEWAY FUNDS INC	91,117	0	For
Lincoln Financial	83,905	0	For
WisdomTree	80,178	0	For
Global X	67,376	0	For
Goldman Sachs	66,033	0	For
Northern Trust	63,724	0	For
AQR	62,143	0	For
AIG/SunAmerica	58,876	0	For
Pacific Life	50,901	0	For
QUANTITATIVE MASTER SERIES LLC	46,319	0	For
Bridge Builder Trust	41,829	0	For
MASTER INVESTMENT PORTFOLIO	34,806	0	For
Voya	33,119	0	For
Brighthouse	0	29,534	Withhold
John Hancock	29,316	0	For
DWS	17,544	0	For
Calvert	0	9,819	Withhold
ProShares	7,748	0	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

3. Elect Director: Michael Ryan

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Meeting held June 11, 2025.

Combines 3 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD

FOR: 32,735,184WITHHELD: 6,192,787

Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Michael Ryan

COHERUS BIOSCIENCES INC.’s own tally for this item (“Elect Director: Michael Ryan”): 32,735,184 for, 6,192,787 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected by a majority of votes cast each of the Class II director nominees below, Jill O'Donnell-Tormey, Ph.D., Michael Ryan and Ali J. Satvat, to the Board of Directors of the Company to hold office until the 2028 annual meeting of stockholders or until their successors …”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 7,643,767 for, 228,695 withheld.

FOR

FOR: 7,643,767WITHHOLD: 228,695

Largest asset managers voting on “To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their ” at COHERUS BIOSCIENCES INC., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	3,202,385	0	For
Charles Schwab	986,197	0	For
Delaware/Macquarie	900,000	0	For
SEI	857,296	0	For
BlackRock	630,808	0	For
Equitable	22,008	188,410	Mixed
Fidelity	177,047	0	For
BRIDGEWAY FUNDS INC	91,117	0	For
Lincoln Financial	83,905	0	For
WisdomTree	80,178	0	For
Global X	67,376	0	For
Goldman Sachs	66,033	0	For
Northern Trust	63,724	0	For
AQR	62,143	0	For
AIG/SunAmerica	58,876	0	For
Pacific Life	50,901	0	For
QUANTITATIVE MASTER SERIES LLC	46,319	0	For
Bridge Builder Trust	41,829	0	For
MASTER INVESTMENT PORTFOLIO	34,806	0	For
Voya	33,119	0	For
Brighthouse	0	29,534	Withhold
John Hancock	29,316	0	For
DWS	17,544	0	For
Calvert	0	9,819	Withhold
ProShares	7,748	0	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

4. TO APPROVE THE TRANSACTION, THE ASSET PURCHASE AGREEMENT AND THE OTHER TRANSACTIONS AND ANCILLARY DOCUMENTS…

No official resultsEXTRAORDINARY TRANSACTIONS

Meeting held March 11, 2025; no official results are on file for this meeting.

100% of fund votes cast · no official result

FOR

Details: description as filed, votes by 36 asset managers

Description as filed by funds: TO APPROVE THE TRANSACTION, THE ASSET PURCHASE AGREEMENT AND THE OTHER TRANSACTIONS AND ANCILLARY DOCUMENTS CONTEMPLATED BY THE ASSET PURCHASE AGREEMENT.

The 36 asset managers below reported 14,969,533 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 14,969,533

Largest asset managers voting on “TO APPROVE THE TRANSACTION, THE ASSET PURCHASE AGREEMENT AND THE OTHER TRANSACTIONS AND ANCILLARY DOCUMENTS CO” at COHERUS BIOSCIENCES INC., 2024-2025
Asset manager	For	Vote
Vanguard	10,761,099	For
SEI	1,024,136	For
Delaware/Macquarie	900,000	For
Charles Schwab	689,973	For
BlackRock	635,979	For
Equitable	236,071	For
Fidelity	121,665	For
Lincoln Financial	83,905	For
Northern Trust	63,724	For
AQR	62,143	For
BRIDGEWAY FUNDS INC	47,027	For
Pacific Life	46,380	For
Bridge Builder Trust	41,829	For
Voya	34,937	For
MASTER INVESTMENT PORTFOLIO	34,806	For
WisdomTree	30,225	For
Brighthouse	29,535	For
John Hancock	18,983	For
Global X	16,261	For
Victory Capital	13,627	For
AIG/SunAmerica	12,327	For
Nationwide	11,892	For
Goldman Sachs	10,450	For
Calvert	9,819	For
ProShares	8,318	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

5. 4. The amendment to the Company's 2014 Employee Stock Purchase Plan (the "ESPP Amendment")

Official resultCOMPENSATIONReported outcome: Approved

Meeting held June 11, 2025.

Combines 3 wordings of this item as funds reported it.

79% Approved · of votes cast

FOR 79%AGAINST

FOR: 27,741,397AGAINST: 7,585,461

Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: To approve the amendment to the Company's 2014 Employee Stock Purchase Plan (the "ESPP Amendment").

COHERUS BIOSCIENCES INC.’s own tally for this item (“4. The amendment to the Company's 2014 Employee Stock Purchase Plan (the "ESPP Amendment")”): 27,741,397 for, 7,585,461 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the amendment to the Company's 2014 Employee Stock Purchase Plan (the "ESPP Amendment").”
Support: 79% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 7,842,928 for, 29,534 against.

FOR

FOR: 7,842,928AGAINST: 29,534

Largest asset managers voting on “To approve the amendment to the Company's 2014 Employee Stock Purchase Plan (the "ESPP Amendment").” at COHERUS BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	3,202,385	0	For
Charles Schwab	986,197	0	For
Delaware/Macquarie	900,000	0	For
SEI	857,296	0	For
BlackRock	630,808	0	For
Equitable	210,418	0	For
Fidelity	177,047	0	For
BRIDGEWAY FUNDS INC	91,117	0	For
Lincoln Financial	83,905	0	For
WisdomTree	80,178	0	For
Global X	67,376	0	For
Goldman Sachs	66,033	0	For
Northern Trust	63,724	0	For
AQR	62,143	0	For
AIG/SunAmerica	58,876	0	For
Pacific Life	50,901	0	For
QUANTITATIVE MASTER SERIES LLC	46,319	0	For
Bridge Builder Trust	41,829	0	For
MASTER INVESTMENT PORTFOLIO	34,806	0	For
Voya	33,119	0	For
Brighthouse	0	29,534	Against
John Hancock	29,316	0	For
DWS	17,544	0	For
Calvert	9,819	0	For
ProShares	7,748	0	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

6. 3. A non-binding, advisory resolution to approve the compensation of the Company's named executive officers (a…

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Meeting held June 11, 2025.

Combines 12 wordings of this item as funds reported it.

54.3% Approved · of votes cast

FOR 54.3%AGAINST

FOR: 19,179,927AGAINST: 16,164,644

Details: description as filed, official tally, votes by 115 asset managers

Description as filed by funds: To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote).

COHERUS BIOSCIENCES INC.’s own tally for this item (“3. A non-binding, advisory resolution to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote)”): 19,179,927 for, 16,164,644 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved a non-binding, advisory resolution to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote).”
Support: 54.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 37 asset managers voting on “To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers” at COHERUS BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	3,202,385	0	0	For
Charles Schwab	0	986,197	0	Against
Delaware/Macquarie	0	900,000	0	Against
SEI	0	857,296	0	Against
BlackRock	630,808	0	0	For
Equitable	22,008	188,410	0	Mixed
Fidelity	0	177,047	0	Against
BRIDGEWAY FUNDS INC	0	91,117	0	Against
Lincoln Financial	83,905	0	0	For
WisdomTree	80,178	0	0	For
Global X	0	67,376	0	Against
Goldman Sachs	0	66,033	0	Against
Northern Trust	0	63,724	0	Against
AQR	0	62,143	0	Against
AIG/SunAmerica	0	58,876	0	Against
Pacific Life	50,901	0	0	For
QUANTITATIVE MASTER SERIES LLC	46,319	0	0	For
Bridge Builder Trust	41,829	0	0	For
MASTER INVESTMENT PORTFOLIO	34,806	0	0	For
Voya	0	33,119	0	Against
Brighthouse	0	0	29,534	Abstain
John Hancock	0	29,316	0	Against
DWS	0	17,544	0	Against
Calvert	9,819	0	0	For
ProShares	0	7,748	0	Against

Fund voting reports, all 37 managers: 4,218,063 for, 3,624,865 against, 29,534 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 92 asset managers voting on “To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers” at COHERUS BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Vote
Rubric Capital Management LP	0	2,550,341	Against
BlackRock	2,122,944	0	For
Kohlberg Kravis Roberts & Co. L.P.	2,055,055	0	For
C WorldWide Asset Management Fondsmaeglerselskab A/S	0	1,928,464	Against
State Street	1,067,631	5,705	For
Charles Schwab	0	986,197	Against
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST	0	900,000	Against
SEI	0	857,723	Against
Stonepine Capital Management, LLC	0	655,000	Against
AQR	0	480,374	Against
Northern Trust	0	479,139	Against
STRS OHIO	0	324,000	Against
MELLON INVESTMENTS Corp	238,788	0	For
GEODE CAPITAL MANAGEMENT, LLC	0	236,102	Against
AllianceBernstein	0	188,410	Against
Vanguard	97,023	33,039	Mixed
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	0	101,584	Against
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0	91,117	Against
Invesco	0	58,872	Against
JPMorgan	50,862	0	For
Corient Private Wealth LLC	50,000	0	For
Rhumbline	0	38,110	Against
Voya	0	33,119	Against
Goldman Sachs	0	30,958	Against
John Hancock	0	29,386	Against

Institutional-manager reports, all 92 managers: 5,726,122 for, 10,283,790 against, 13,000 not voted. Showing the 25 largest; see all in the interactive database.

7. 2. The selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its…

Official resultAUDIT-RELATEDReported outcome: Approved

Meeting held June 11, 2025.

99% Approved · of votes cast

FOR 99%

FOR: 74,500,950AGAINST: 776,953

Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: TO RATIFY THE SELECTION, BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS, OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

COHERUS BIOSCIENCES INC.’s own tally for this item (“2. The selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025”): 74,500,950 for, 776,953 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 7,841,996 for, 932 against, 29,534 abstained.

FOR

FOR: 7,841,996AGAINST: 932ABSTAIN: 29,534

Largest asset managers voting on “TO RATIFY THE SELECTION, BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS, OF ERNST & YOUNG LLP AS OUR INDEPEN” at COHERUS BIOSCIENCES INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	3,202,385	0	For
Charles Schwab	986,197	0	For
Delaware/Macquarie	900,000	0	For
SEI	857,296	0	For
BlackRock	630,808	0	For
Equitable	210,418	0	For
Fidelity	177,047	0	For
BRIDGEWAY FUNDS INC	91,117	0	For
Lincoln Financial	83,905	0	For
WisdomTree	80,178	0	For
Global X	67,376	0	For
Goldman Sachs	66,033	0	For
Northern Trust	63,724	0	For
AQR	62,143	0	For
AIG/SunAmerica	58,876	0	For
Pacific Life	50,901	0	For
QUANTITATIVE MASTER SERIES LLC	46,319	0	For
Bridge Builder Trust	41,829	0	For
MASTER INVESTMENT PORTFOLIO	34,806	0	For
Voya	33,119	0	For
Brighthouse	0	29,534	Abstain
John Hancock	29,316	0	For
DWS	17,544	0	For
Calvert	9,819	0	For
ProShares	7,748	0	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

Largest COHERUS BIOSCIENCES INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 114,725,740 shares outstanding at the time of that meeting.

Fund voting reports: top COHERUS BIOSCIENCES INC. shareholders by shares voted on “To vote on a non-binding, advisory basis to approve the compensation of the Company's named…”, 2024-2025
#	Asset manager	% of shares outstanding
1	Vanguard	2.79%
2	Charles Schwab	0.86%
3	Delaware/Macquarie	0.78%
4	SEI	0.75%
5	BlackRock	0.55%
6	Equitable	0.18%
7	Fidelity	0.15%
8	BRIDGEWAY FUNDS INC	0.08%
9	Lincoln Financial	0.07%
10	WisdomTree	0.07%

Institutional-manager reports: top COHERUS BIOSCIENCES INC. shareholders by shares voted on “To vote on a non-binding, advisory basis to approve the compensation of the Company's named…”, 2024-2025
#	Asset manager	% of shares outstanding
1	Rubric Capital Management LP	2.22%
2	BlackRock	1.85%
3	Kohlberg Kravis Roberts & Co. L.P.	1.79%
4	C WorldWide Asset Management Fondsmaeglerselskab A/S	1.68%
5	State Street	0.94%
6	Charles Schwab	0.86%
7	MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST	0.78%
8	SEI	0.75%
9	Stonepine Capital Management, LLC	0.57%
10	AQR	0.42%

Reported COHERUS BIOSCIENCES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

COHERUS BIOSCIENCES INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Vanguard Group	9.72%	13F
BlackRock	9.57%	13F
Evgeny Zaytsev ("Zaytsev")	6.63%	13G
Thomas A. Satterfield, Jr.	6.04%	13G
Ali J. Satvat	2.65%	DEF14A
Millennium Management	2.53%	13F
State Street	1.94%	13F
Dennis M. Lanfear	1.05%	DEF14A
Northern Trust	0.83%	13F
Goldman Sachs	0.48%	13F

Percentages above are of 114,725,740 shares outstanding, as reported by COHERUS BIOSCIENCES INC. on its Form 10-Q dated April 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from COHERUS BIOSCIENCES INC.’s 10-Q dated April 30, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At COHERUS BIOSCIENCES INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held March 11, 2025 and June 11, 2025), 116 asset managers reported how they voted in their SEC Form N-PX filings, covering 855 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held June 11, 2025 — To vote on a non-binding, advisory basis to approve the compensation of the Company's named… — COHERUS BIOSCIENCES INC.'s filing reports the proposal as approved, with 54.3% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: COHERUS BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2025.

COHERUS BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.